Related Experiment Video
Updated: May 1, 2026
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
MC4R Antagonists: A Promising New Hope for the Treatment of Cachexia and Wasting Diseases
Jiajia Shi1, Jiaying Xiong2, Chao Hao1
1Jiangsu Key Laboratory of Marine Biological Resources and Environment, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, School of Pharmacy, Jiangsu Ocean University, 222005 Lianyungang, Jiangsu, China.
Abstract:
Melanocortin-4 receptor (MC4R) is a key receptor in the hypothalamus regulating appetite and energy metabolism. Research has indicated that MC4R agonists have demonstrated potential for weight loss; its antagonists may stimulate appetite and weight gain, showing potential therapeutic applications in patients with anorexia or cachexia or those requiring weight restoration. However, the signaling mechanism, clinical applications, and safety profile of MC4R antagonists still require in-depth investigation. The purpose of this review is to comprehensively summarize the research progress of MC4R antagonists, analyze their mechanism of action and clinical applications, evaluate their safety profile, and explore future research directions. Future studies should focus on developing safer and more effective MC4R antagonists and exploring the therapeutic potential of MC4R in other diseases.
Insights
Melanocortin-4 receptor (MC4R) antagonists show promise for stimulating appetite and weight gain, offering therapeutic potential for conditions like anorexia. Further research is needed to fully understand their mechanisms, applications, and safety.
Area of Science:
- Neuroendocrinology
- Pharmacology
Background:
- The melanocortin-4 receptor (MC4R) plays a crucial role in regulating appetite and energy balance within the hypothalamus.
- MC4R agonists are explored for weight loss, while antagonists may promote appetite and weight gain.
Purpose of the Study:
- To comprehensively review the research progress of MC4R antagonists.
- To analyze their mechanisms of action, clinical uses, and safety profiles.
- To identify future research directions for MC4R antagonists.
Main Methods:
- Literature review and synthesis of existing research on MC4R antagonists.
- Analysis of preclinical and clinical data regarding efficacy and safety.
- Exploration of potential therapeutic targets and disease applications.
Main Results:
- MC4R antagonists demonstrate potential for stimulating appetite and inducing weight gain.
- Current understanding of their signaling pathways, clinical efficacy, and safety requires further investigation.
- Potential applications include treating anorexia, cachexia, and facilitating weight restoration.
Conclusions:
- MC4R antagonists represent a promising therapeutic avenue for conditions characterized by appetite loss and weight deficit.
- Continued research is essential to optimize their development, ensuring safety and efficacy.
- Exploring MC4R's broader therapeutic potential in other diseases is warranted.
More Related Videos
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
10:30Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
